Literature DB >> 28363336

Active efflux in dormant bacterial cells - New insights into antibiotic persistence.

Yingying Pu1, Yuehua Ke2, Fan Bai3.   

Abstract

Bacterial persisters are phenotypic variants of an isogenic cell population that can survive antibiotic treatment and resume growth after the antibiotics have been removed. Cell dormancy has long been considered the principle mechanism underlying persister formation. However, dormancy alone is insufficient to explain the full range of bacterial persistence. Our recent work revealed that in addition to 'passive defense' via dormancy, persister cells employ 'active defense' via enhanced efflux activity to expel drugs. This finding suggests that persisters combine two seemingly contradictory mechanisms to tolerate antibiotic attack. Here, we review the passive and active aspects of persister formation, discuss new insights into the process, and propose new techniques that can facilitate the study of bacterial persistence.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Keywords:  Antibiotic persistence; Dormancy; Efflux pumps; Passive and active defense

Mesh:

Substances:

Year:  2016        PMID: 28363336     DOI: 10.1016/j.drup.2016.11.002

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  17 in total

Review 1.  Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells.

Authors:  Mesrop Ayrapetyan; Tiffany Williams; James D Oliver
Journal:  J Bacteriol       Date:  2018-09-24       Impact factor: 3.490

2.  Evolution of Bacterial Persistence to Antibiotics during a 50,000-Generation Experiment in an Antibiotic-Free Environment.

Authors:  Hugo Mathé-Hubert; Rafika Amia; Mikaël Martin; Joël Gaffé; Dominique Schneider
Journal:  Antibiotics (Basel)       Date:  2022-03-27

3.  Formation of persisters in Streptococcus mutans biofilms induced by antibacterial dental monomer.

Authors:  Suping Wang; Chenchen Zhou; Biao Ren; Xiaodong Li; Michael D Weir; Radi M Masri; Thomas W Oates; Lei Cheng; Hockin K H Xu
Journal:  J Mater Sci Mater Med       Date:  2017-10-04       Impact factor: 3.896

4.  Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.

Authors:  Divakara S S M Uppu; Mohini M Konai; Paramita Sarkar; Sandip Samaddar; Isabel C M Fensterseifer; Celio Farias-Junior; Paramanandam Krishnamoorthy; Bibek R Shome; Octávio L Franco; Jayanta Haldar
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

5.  Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.

Authors:  Jodi Wong; Stephen Yiu Chuen Choi; Rongrong Liu; Eddie Xu; James Killam; Peter W Gout; Yuzhuo Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-02-12       Impact factor: 5.293

6.  Reversing resistance to counter antimicrobial resistance in the World Health Organisation's critical priority of most dangerous pathogens.

Authors:  Henrietta Venter
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

7.  Starvation Survival and Biofilm Formation under Subminimum Inhibitory Concentration of QAMs.

Authors:  Sanjay Kumar Tiwari; Suping Wang; Yannan Huang; Xuedong Zhou; Hockin H K Xu; Biao Ren; Xian Peng; Yan Xiao; Mingyun Li; Lei Cheng
Journal:  Biomed Res Int       Date:  2021-01-14       Impact factor: 3.411

8.  A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms.

Authors:  Christian Kranjec; Sofie S Kristensen; Karolina T Bartkiewicz; Mikkel Brønner; Jorunn P Cavanagh; Aparna Srikantam; Geir Mathiesen; Dzung B Diep
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

9.  Curcumin alleviates persistence of Acinetobacter baumannii against colistin.

Authors:  Amanjot Kaur; Prince Sharma; Neena Capalash
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

10.  Non-walled spherical Acinetobacter baumannii is an important type of persister upon β-lactam antibiotic treatment.

Authors:  Jin Zou; Si-Hoi Kou; Ruiqiang Xie; Michael S VanNieuwenhze; Jiuxin Qu; Bo Peng; Jun Zheng
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.